Healthcare CMO Market is expected to reach US$ 223,355.6 Mn by 2027 with a CAGR of 12.2% Till-2027 with Royal DSM, Catalent, Inc, Boehringer Ingelheim International GmbH, Recipharm AB (publ), Fareva, Lonza and others

Research Reports

May 27, 2021

According to The Insight Partners market research study titled ‘Healthcare CMO Market to 2027 – Global Analysis and Forecasts by Service and Geography. The global healthcare CMO market is expected to reach US$ 223,355.6 Mn in 2027 from US$ 80,479.4 in 2018. The market is estimated to grow with a CAGR of 12.2% from 2019-2027. The report highlights the trends prevalent in the global healthcare CMO market and the factors driving the market along with those that act as challenges to its growth.

Download Sample PDF Report Copy at: https://www.theinsightpartners.com/sample/TIPRE00003263/

Market Insights

Increasing Inclination of Pharmaceutical and Medical Device Manufacturers Towards Outsourcing

The growth of the healthcare contract manufacturing organizations market is growing owing to the advantages offered by the contract manufacturing companies. These companies provides services to the pharmaceutical, biopharmaceutical and medical device companies. For the biopharmaceutical and pharmaceutical companies the CMO offers various beneficial services right form the producing of small quantities of materials for R&D purposes, larger amounts for clinical study and eventually large-scale production for commercialization. On the other hand the CMO helps medical devices companies meet the rising demands from the customers. The companies invest majorly on the R&Ds with the aim of delivering high quality and innovative products to the market. The rising demands for the healthcare products such as medicines, vaccines, diagnostics devices, implants and other therapeutic medicines and devices are likely to drive the contract manufacturing. Therefore, owing this factor the market for the healthcare CMO is likely to significantly in the forecast period.

Rising Demand in Developing Regions

The developing regions such as Asia Pacific and Middle East, Africa and Latin America are growing dynamically in the biotechnology and pharmaceutical sectors. The governments of the respective countries in these regions are supporting through various initiatives, funding, programs and conferences. The growth of the pharmaceutical and biotechnology is driven by the economic, demographic development, rising healthcare expenditures, and improving public-private healthcare funding among the others. Asia Pacific have a great potential to serve the medical device industry. Thus, owing to the above mentioned factors the developing regions are likely to create growth opportunities for the healthcare CMO market during the forecast period.

Strategic Insights

Mergers and agreements were observed as the most adopted strategy in global healthcare CMO industry. Few of the recent market consolidations are listed below:

2018: In October, 2018, Recipharm acquired Sanofi’s inhalation contract manufacturing business including a manufacturing facility located in Holmes Chapel, UK to expand its full service offering to include specialist, in-demand capabilities.

2017: In February, 2017, Catalent Pharma Solutions acquired Accucaps Industries Limited to expand Softgel development and manufacturing capabilities and capacity in Canada.

2015: In May 2015, Lonza and Nikon signed a collaboration in the field of cell and gene therapy manufacturing in Japan.

Global healthcare CMO market, based on service was segmented as, pharmaceutical contract manufacturing services and medical device contract manufacturing services. In 2018, the pharmaceutical contract manufacturing services held the largest share of the market, by service. Additionally, the segment is also expected to grow at the fastest CAGR during the forecast period owing to advantaged offered by the contract manufacturing companies.

The market for healthcare CMO is expected to grow significantly due to factor as increasing inclination of pharmaceutical and medical device manufacturers towards outsourcing, increasing patent cliffs and rising geriatric population coupled with the increasing production of drugs & medical devices. However, the challenge such as lack of skilled professionals for CMO likely to impact the growth of the market in the forecast period.

The major players operating in the healthcare CMO market include, Royal DSM, Catalent, Inc, Boehringer Ingelheim International GmbH, Recipharm AB (publ), Fareva, Lonza, Piramal Enterprises Ltd, Dr. Reddy’s Laboratories Ltd., Almac Group, FAMAR Health Care Services. The market is has provided inorganic growth strategies to these companies by various market consolidations. For instance, during February 2018, Lonza and Denali Therapeutics entered into a partnership for neurodegenerative diseases that covers all stages of the development and manufacturing.

The report segments the global healthcare CMO market as follows:

Global Healthcare CMO Market – By Service

Pharmaceutical Contract Manufacturing Services
- Active Pharmaceutical Ingredients (API) Manufacturing
- Final Dosage Form Manufacturing
- Packaging
Medical Device Contract Manufacturing Services
- Outsourcing Design
- Device Manufacturing
- Final Goods Assembly

Global Healthcare CMO Market – By Geography

North America
- U.S
- Canada
- Mexico
Europe
- France
- Germany
- U.K
- Italy
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
South & Central America
- Brazil
- Argentina

TABLE OF CONTENT

1. INTRODUCTION
2. GLOBAL HEALTHCARE CMO MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. GLOBAL HEALTHCARE CMO– MARKET LANDSCAPE
5. GLOBAL HEALTHCARE CMO MARKET – KEY MARKET DYNAMICS
6. HEALTHCARE CMO MARKET – GLOBAL ANALYSIS
7. GLOBAL HEALTHCARE CMO MARKET ANALYSIS– BY SERVICE
8. HEALTHCARE CMO MARKET REVENUE AND FORECASTS TO 2027 – GEOGRAPHICAL ANALYSIS
9. HEALTHCARE CMO MARKET – INDUSTRY LANDSCAPE
10. HEALTHCARE CMO MARKET–KEY COMPANY PROFILES
10.1 ROYAL DSM
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Financial Overview
10.1.4 Service Portfolio
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 CATALENT, INC
10.3 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
10.4 RECIPHARM AB (PUBL)
10.5 FAREVA
10.6 LONZA
10.7 PIRAMAL ENTERPRISES LTD.
10.8 DR. REDDY’S LABORATORIES LTD.
10.9 ALMAC GROUP
10.10 FAMAR HEALTH CARE SERVICES
11. APPENDIX

REASONS TO BUY

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the healthcare CMO market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global healthcare CMO market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Buy Complete Report at: https://www.theinsightpartners.com/buy/TIPRE00003263/

Tags: Healthcare CMO Market Type, Healthcare CMO Market Analysis Report, Healthcare CMO Insight, Healthcare CMO Industry Analysis, Healthcare CMO Research Reports, Healthcare CMO Market Overview, Healthcare CMO Market Insights, Healthcare CMO Market Outlook, Healthcare CMO market share, Healthcare CMO Market, Healthcare CMO, , Healthcare CMO Market Size, Healthcare CMO Market Trends, Healthcare CMO Market Analysis, Healthcare CMO Market Forecast See Campaign: https://www.theinsightpartners.com/reports/healthcare-cmo-market
Contact Information:
Sameer Joshi +1-646-491-9876 [email protected]